Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.
By Marin Kollef. Clinical Infectious Diseases, 2000
653 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Clinical Biochemistry, Critical Care and Intensive Care Medicine
View Paper: https://www.semanticscholar.org/paper/64862b3c81198f993fd3b2b5f59491471a02d933
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Clinical Biochemistry
In Critical Care and Intensive Care Medicine
Citations in the corpus
- Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality (2005, background): “, hospital-acquired pneumonia and bloodstream infections) are associated with greater rates of hospital mortality (11, 12, 17).”
- Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. (2008, background): “One of the consequences of increasing antimicrobial resistance is an increased probability of inappropriate initial empiric antimicrobial treatment of infections (228).”
- Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome (2004, background): “aeruginosa infection, and antibiotic-resistant bacteria (14).”
- Antimicrobial Stewardship Programs in Health Care Systems (2005, background): “aeruginosa) are more likely to receive inappropriate therapy (82, 84, 99); thus, as the incidence of resistance in hospitals increases, a greater number of patients are at risk for the adverse sequelae of inappropriate therapy.”
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria (2012, background): “However, when identification and susceptibility testing results are known, an argument can be made that the antibiotic regimen for Gram-negative organisms can be “fine-tuned” and narrowed in many cases (20, 134).”
- Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. (2012, background): “This is important since rapid and appropriate antimicrobial therapy is pivotal to reduce poor outcome (Kollef, 2000).”